Potent Antitumor Activity of Ensartinib in MET Exon 14 Skipping-Mutated Non-Small Cell Lung Cancer

Molecular simulation was conducted to evaluate ensartinib c-MET interaction, and cell lines, patient-derived organoids, and xenograft models were used to test the effectiveness of ensartinib.